BCBS FEP medication denied: how to appeal

Quick answer

If BCBS Federal Employee Program (FEP) denied your medication and prescription, you can appeal, and the plan must give you its file and the criteria it used. You have 6 months for carrier reconsideration (FEHB) to file. The date printed on your denial notice controls; it can only be later than these floors, never earlier.

Why BCBS Federal Employee Program (FEP) denies medication and prescription

The BCBS Federal Employee Program is the largest carrier in the Federal Employees Health Benefits (FEHB) program. Because FEHB is regulated by the U.S. Office of Personnel Management (OPM), the appeal process bypasses state insurance departments and ends with OPM rather than a state IRO.

For medication and prescription specifically: Drug denials happen at the pharmacy benefit (PBM) layer, separate from the medical benefit. They include non-formulary drugs, GLP-1s, specialty injectables, brand-name vs. generic, and prior-auth-required medications.

The law that controls this appeal

Formulary tiering and exception rights, including the standard and expedited exception process ACA plans must offer under 45 C.F.R. § 156.122.

Note for BCBS Federal Employee Program (FEP): where the standard above cites ERISA or the ACA appeal rules, those describe employer and Marketplace plans. The windows and levels that apply to BCBS Federal Employee Program (FEP) are in the table below.

At a glance

BCBS Federal Employee Program (FEP) appeals: the rule, the deadline and the next level, by plan type

FEHB plans follow federal rules that pre-empt state insurance law. ERISA and state external review do not apply.

Plan type	Rule that governs	File your appeal within	The plan must answer	If the plan says no again
Federal Employees Health Benefits (FEHB) Federal employees, annuitants and their families. The plan brochure is the contract.	5 U.S.C. § 8902 and 5 CFR 890.105 (disputed claims), 890.107 (court review). FEHB law pre-empts state insurance law; ERISA does not apply.	Ask the carrier in writing to reconsider within 6 months of the denial (5 CFR 890.105(a)(1)). If the carrier affirms, ask OPM to review within 90 days of the carrier's reconsideration decision (§ 890.105(e)).	The carrier answers a reconsideration request within 30 days (5 CFR 890.105(c)); OPM's review generally takes up to 60 days once the file is complete (§ 890.105(e)).	OPM disputed-claims review, then suit against OPM in federal court after OPM's final decision (5 CFR 890.107(c)).

Federal Employees Health Benefits (FEHB)

What you can demand. The plan brochure and the carrier's written reconsideration are the record. Ask the carrier for the specific brochure provision and the criteria it relied on.

How to open the appeal. Cite 5 CFR 890.105 and the brochure section at issue: state that the request is a reconsideration under FEHB rules and ask for the criteria and the file.

Primary sources for this table

Windows are federal floors or the rule as written; the denial notice controls. Reviewed 13 September 2026. General information, not legal advice; Apellica is not a law firm.

What BCBS Federal Employee Program (FEP) denies for medication and prescription

The medication and prescription services most often denied:

GLP-1s (Ozempic, Wegovy, Mounjaro, Zepbound)
Specialty biologics (Humira, Stelara, Dupixent)
ADHD medications (Vyvanse, Adderall XR)
Hepatitis C antivirals
Hormone replacement therapy
Compounded medications
Off-label prescription uses

Why medication and prescription claims get denied

A typical BCBS Federal Employee Program (FEP) medication and prescription denial almost always cites one of these reasons. Each one maps to a specific rebuttal in the appeal:

Drug not on plan formulary (non-formulary)
Step therapy: cheaper alternative not tried first
Quantity limit exceeded
Plan claims indication not FDA-approved
Diagnosis ICD doesn't match approved indication

The BCBS Federal Employee Program (FEP) appeal process

Appeal levels: Internal reconsideration by BCBS FEP, then administrative appeal to OPM, then federal district court under FEHBA.

Carrier timing: Internal reconsideration: typically within 6 months of denial. OPM appeal: within 90 days of final internal denial. Carrier response timeframes mirror ACA standards (30 days standard, 72 hours urgent).

Medication timing for BCBS Federal Employee Program (FEP): the filing windows and decision clocks in the table above apply; the date on the notice controls.

What we know about BCBS Federal Employee Program (FEP): FEP appeals require precise citation to the year-specific FEHB brochure. We pull the exact brochure provisions in force on the date of service and brief OPM accordingly.

Common BCBS Federal Employee Program (FEP) denial patterns for medication and prescription

OPM is the final reviewer, not the state DOI. After BCBS FEP's internal reconsideration, members appeal to OPM's Healthcare and Insurance office, not to a state external review program. OPM's decision is binding on the carrier and is the prerequisite to any federal-court action.
FEHB brochure controls coverage scope. Every FEHB plan publishes a brochure (the SF-2809-series document) that is the contractually binding statement of benefits for the year. Appeals that quote the brochure language verbatim and contrast it with the denial reason produce a strong record.
Federal court review under FEHBA. After OPM final decision, members may seek judicial review under the Federal Employees Health Benefits Act. The standard of review is generally whether OPM's decision was arbitrary and capricious, so a complete administrative record is essential.

How to win your BCBS Federal Employee Program (FEP) medication and prescription appeal

Strategy for medication and prescription: Two paths: (1) tiering exception, request that the drug be moved to a covered tier; (2) formulary exception, request coverage of a non-formulary drug citing medical necessity. Manufacturer-published clinical packets accelerate exception filings.

Filed against BCBS Federal Employee Program (FEP), that strategy rides on this procedural spine:

Procedural-rights anchor. Cite 5 CFR 890.105 and the brochure section at issue: state that the request is a reconsideration under FEHB rules and ask for the criteria and the file.
Criteria-disclosure demand. BCBS Federal Employee Program (FEP) frequently denies on "not medically necessary" without disclosing the clinical criteria applied. Once disclosed, those criteria become the rebuttal map.
Controlling-standard citation. Formulary tiering and exception rights, including the standard and expedited exception process ACA plans must offer under 45 C.F.R. § 156.122.
Treating-provider attestation. A letter from the treating physician addressing each criterion in BCBS Federal Employee Program (FEP)'s own policy language. This is the single strongest evidentiary element.
Requested action. A specific demand to reverse the medication and prescription denial and approve the service, not a general "please reconsider."

Documents you'll need for your BCBS Federal Employee Program (FEP) medication and prescription appeal

Denial letter from pharmacy benefit
Prescription / Rx record
Prescriber's notes on indication
Documentation of prior step-therapy trials

What a medication and prescription appeal can recover

Typical recovery for medication and prescription cases runs $200 - $20,000+ per month of medication. The exact figure depends on the specific service and your plan's contracted rates.

BCBS Federal Employee Program (FEP) medication and prescription appeals: frequently asked questions

Can I appeal your BCBS Federal Employee Program (FEP) prescription denial?

Yes. Drug denials happen at the pharmacy-benefit layer and have two appeal paths: a tiering exception to move a covered drug to a lower-cost tier, or a formulary exception to cover a non-formulary drug on medical-necessity grounds.

How fast is your BCBS Federal Employee Program (FEP) medication appeal decided?

Urgent requests are decided in 24 to 72 hours. Standard requests take 72 hours for Medicare Part D and up to 15 days for commercial plans. The filing window is typically 60 days.

Why was my drug denied as non-formulary or step therapy?

Plans deny when a drug is off-formulary, when a cheaper alternative has not been tried first (step therapy), when a quantity limit is exceeded, or when the diagnosis code does not match the approved indication. Manufacturer clinical packets accelerate exception filings.

What documents support your BCBS Federal Employee Program (FEP) medication exception?

The pharmacy-benefit denial letter, the prescription record, the prescriber's notes on the indication, and documentation of any prior step-therapy trials and their outcomes.

What Apellica does for BCBS Federal Employee Program (FEP) medication and prescription appeals

We file appeals against BCBS Federal Employee Program (FEP) specifically configured to its internal review process. Every medication and prescription appeal embeds the criteria-disclosure demand, the procedural-rights anchor, the controlling-standard citation above, treating-provider attestation language, and the peer-reviewed evidence relevant to the denied service.

Cost: $0 upfront. We work on contingency for BCBS Federal Employee Program (FEP) appeals, if the appeal succeeds, we collect a percentage of the recovered claim value. If it fails, you owe nothing.

Start your BCBS Federal Employee Program (FEP) medication and prescription appeal

Submit a 2-minute intake. A senior reviewer responds within one business day with the specific appeal strategy for your case.

Start free appeal review →

BCBS Federal Employee Program (FEP) denied your medication and prescription? Here is what to do next